These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9806317)

  • 1. Evaluation of pre- and postprandial growth hormone (GH)-releasing hormone-induced GH response in subjects with persistent body weight normalisation after biliopancreatic diversion.
    De Marinis L; Mancini A; Valle D; Tacchino RM; Bianchi A; Gentilella R; Perrelli M; Castagneto M; Gasbarrini G
    Int J Obes Relat Metab Disord; 1998 Oct; 22(10):1011-8. PubMed ID: 9806317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.
    Mancini A; Bianchi A; Tacchino RM; Perrelli M; Milardi D; Gentilella R; Giampietro A; Fusco A; Valle D; De Marinis L
    Metabolism; 2001 Apr; 50(4):382-6. PubMed ID: 11288030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
    Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
    Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
    Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
    Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects.
    De Marinis L; Mancini A; Valle D; Izzi D; Bianchi A; Gentilella R; Giampietro A; Desenzani P; Giustina A
    Horm Metab Res; 2000 Apr; 32(4):152-6. PubMed ID: 10824712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Haijma SV; van Dam PS; de Vries WR; Maitimu-Smeele I; Dieguez C; Casanueva FF; Koppeschaar HP
    Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.
    De Marinis L; Folli G; D'Amico C; Mancini A; Sambo P; Tofani A; Oradei A; Barbarino A
    J Clin Endocrinol Metab; 1988 Mar; 66(3):598-604. PubMed ID: 3127419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism.
    Villa P; Soranna L; Mancini A; De Marinis L; Valle D; Mancuso S; Lanzone A
    Hum Reprod; 2001 Mar; 16(3):430-4. PubMed ID: 11228207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.